New use of clonazepam, levetiracetam, or topiramate was not associated with Stevens-Johnson syndrome and toxic epidermal necrolysis.
The relative risk of seizure disorder is higher in women who were affected by eclampsia than those who were not.
The FDA has approved lacosamide for treating pediatric patients with partial-onset seizures.
Of 84 products sampled, 42.85% were underlabeled and 26.19% were overlabeled.
Infection with the Zika virus may increase the risk for development of Guillain-Barré syndrome.
Surgery can improve freedom from seizures in pediatric patients with drug-resistant epilepsy.
Infants born at 32-36 weeks gestation from 1978-2008 with infant respiratory distress syndrome were enrolled to evaluate the long term risk of epilepsy.
Risk for mortality in posttraumatic epilepsy is high, and negative outcomes affecting cognitive, affective, and physical function are common.
A model comprising 6 variables can identify the probability of seizure for critically ill patients.
Previous research found an association between AED use and reduced bone density in adults.
A "ceiling" may exist for lamotrigine therapy above which remission from seizures may be unlikely.
The system includes a detect-and-respond mode, which is designed to prevent seizures before they start and deliver therapy to stop them if they do.
The CDC has updated the US national estimate of epilepsy prevalence and estimates 3.4 million people are affected by epilepsy.
Patients with sepsis included in this analysis may have presented with other CNS pathologies that could have contributed to seizure risk.
Newer antiepileptic drugs were associated with fewer adverse effects in patients with ischemic stroke.
Pregnant women on antiepileptic drugs are at a higher risk of giving birth to a premature and SGA infant.
The FDA has approved an expanded indication for Aptiom to treat pediatric partial-onset seizures.
Briviact was initially approved as adjunct treatment for partial-onset seizures.
Rectal diazepam is currently the only FDA-approved treatment for pediatric status epilepticus.
Over 1% of the US population reported active or current epilepsy in 2015.
While several studies have demonstrated efficacy in refractory epilepsy, it is still not clear how cannabidiol may have an impact on current epilepsy treatments.
Brexanolone may help wean patients with super-refractory status epilepticus off of third-line agents.
For people with seizures, levetiracetam is more effective than carbamazepine and lamotrigine.
In children with epilepsy, genetic investigation that emphasizes sequencing tests should be part of the initial evaluation.
Previous research has found a higher prevalence of depression before and after an epilepsy diagnosis.
The FDA has expanded the age range for the VNS Therapy system.
Potiga tablets have been discontinued due to the limited use of the medicine.
Woman with SLE complains of headache, confusion, and mild somnolence to the emergency department.
The FDA-sponsored study sought to evaluate the bioequivalence of 2 generic forms of the popular epilepsy treatment lamotrigine.
Epileptic phenomena are an important component of the dysfunction of the neuronal networks affected by Alzheimer's disease.
Neurology Advisor Articles
- Coffee Consumption May Decrease Stroke Risk
- Prochlorperazine More Effective Than Ketamine for Headache Relief in the Emergency Department
- CTE Confirmed With Antemortem PET Imaging, Autopsy in Professional Football Player
- Intranasal Sumatriptan More Effectively Reduces Migraine-Associated Nausea
- Neuropsychiatric Conditions Common in Relatives of Patients With Amyotrophic Lateral Sclerosis
- Treating Cluster Headache: Weighing Current Therapies
- Alzheimer Disease Linked to High Cumulative Doses of Zolpidem in Elderly
- NBT System Gets FDA Clearance for Depression Treatment
- Better Migraine Pain Relief With IV Non-Opioid Combination vs IV Hydromorphone
- FDA Approves Myasthenia Gravis Treatment
- Reports of Agranulocytosis Prompt Monitoring for Investigational Parkinson's Drug
- Nusinersen Improves Motor Function, Survival in Infants With Spinal Muscular Atrophy
- Noninvasive Brain Stimulation System Approved for Depression
- Hypertension Guidelines Updated by AHA/ACA
- Bone Mineral Density Associated With Intracranial Aneurysm Presence, Size